EvokAI Creative Labs Inc.

Healthcare CA OKAI

0.115CAD
0.00(0%)

Last update at 2026-06-19T13:30:00Z

Day Range

0.120.12

LowHigh

52 Week Range

0.120.12

LowHigh

Fundamentals

Previous Close 0.12
Market Cap0.87M
Volume0
P/E Ratio-
Dividend Yield-%
Revenue TTM0.01M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-2.32

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Income before tax	-17.08335M	-0.71538M	-0.08608M
Minority interest	-	-	-
Net income	-17.08335M	-0.71538M	-0.08608M
Selling general administrative	1.85M	0.30M	0.01M
Selling and marketing expenses	-	-	-
Gross profit	-	-	-
Reconciled depreciation	-	-	-
Ebit	-	-	-
Ebitda	-	-	-
Depreciation and amortization	-	-	-
Non operating income net other	-	-	-
Operating income	-2.34212M	-0.71538M	-0.08608M
Other operating expenses	-	-	-
Interest expense	0.02M	0.00000M	-
Tax provision	-	-	-
Interest income	-	-	-
Net interest income	-0.01768M	0.00000M	-
Extraordinary items	-	-	-
Non recurring	-	-	-
Other items	-	-	-
Income tax expense	-	-	-
Total revenue	0.00000M	0.00000M	0.00000M
Total operating expenses	2.34M	0.72M	0.09M
Cost of revenue	-	-	-
Total other income expense net	-14.72356M	-	-
Discontinued operations	-	-	-
Net income from continuing ops	-17.08335M	-0.71538M	-0.08608M
Net income applicable to common shares	-	-	-
Preferred stock and other adjustments	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Total assets	0.87M	0.00406M	0.06M
Intangible assets	-	-	-
Earning assets	-	-	-
Other current assets	-	-	-
Total liab	1.16M	0.66M	0.00000M
Total stockholder equity	-0.28434M	-0.66015M	0.06M
Deferred long term liab	-	-	-
Other current liab	-	-	-
Common stock	-	-	-
Capital stock	18.76M	3.64M	3.64M
Retained earnings	-21.38545M	-4.30210M	-3.58671M
Other liab	-	-	-
Good will	-	-	-
Other assets	-	-	-
Cash	0.77M	0.00406M	0.00534M
Cash and equivalents	-	-	-
Total current liabilities	0.48M	0.66M	0.00000M
Current deferred revenue	-	-	-
Net debt	0.01M	0.04M	-
Short term debt	-	-	-
Short long term debt	0.11M	0.05M	-
Short long term debt total	-	-	-
Other stockholder equity	-	-	-
Property plant equipment	-	-	-
Total current assets	0.87M	0.00406M	0.06M
Long term investments	-	-	-
Net tangible assets	-	-	-
Short term investments	-	-	-
Net receivables	0.03M	0.00000M	0.00228M
Long term debt	0.68M	-	-
Inventory	-	-	-
Accounts payable	-	0.16M	0.00774M
Total permanent equity	-	-	-
Noncontrolling interest in consolidated entity	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-
Accumulated other comprehensive income	-	-	-
Additional paid in capital	-	-	-
Common stock total equity	-	-	-
Preferred stock total equity	-	-	-
Retained earnings total equity	-	-	-
Treasury stock	-	-	-
Accumulated amortization	-	-	-
Non currrent assets other	-	-	-
Deferred long term asset charges	-	-	-
Non current assets total	0.00000M	0.00000M	0.00000M
Capital lease obligations	-	-	-
Long term debt total	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31
Investments	-	-	-
Change to liabilities	-	-	-
Total cashflows from investing activities	-	-	-
Net borrowings	-0.10941M	0.00000M	0.00000M
Total cash from financing activities	-0.10941M	0.00000M	0.00000M
Change to operating activities	-	-	-
Net income	-17.08335M	-0.71538M	-0.08608M
Change in cash	0.77M	-0.00127M	-0.08969M
Begin period cash flow	0.00406M	0.00534M	0.13M
End period cash flow	0.77M	0.00406M	0.04M
Total cash from operating activities	-2.53416M	-0.00117M	-0.08969M
Issuance of capital stock	-	0.24M	0.00000M
Depreciation	-	-	-
Other cashflows from investing activities	-	-	-
Dividends paid	-	-	-
Change to inventory	-	-	-
Change to account receivables	-0.05786M	0.00000M	-
Sale purchase of stock	-	-	-
Other cashflows from financing activities	-	-	-
Change to netincome	-	-	-
Capital expenditures	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-
Cash flows other operating	-	-	-
Exchange rate changes	-	-	-
Cash and cash equivalents changes	-	-	-
Change in working capital	-0.79869M	0.71M	-0.00362M
Stock based compensation	0.61M	0.00000M	-
Other non cash items	2.08M	0.00077M	-
Free cash flow	-2.53416M	-0.00117M	-0.08969M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to EBITDA (x)
OKAI EvokAI Creative Labs Inc.	- -%	0.12	-	-	714.86	-	-19.4857
NURS Hydreight Technologies Inc	0.26 6.13%	4.50	406.00	25.91	7.85	20.38	7.45	109.02
RHT Reliq Health Technologies Inc	- -%	0.21	-	-	3.19	5.12	4.07	-10.7759
ADK Diagnos Inc	-0.005 2.17%	0.23	-	10.00	411.24	18.74	389.06	-6.1551
NXG NexgenRX Inc.	0.02 4.44%	0.47	39.00	32.68	1.55	4.64	1.39	7.84

Reports Covered

View All

Profile

EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.

EvokAI Creative Labs Inc.

609 Granville Street, Vancouver, BC, Canada, V7Y 1C3

https://www.evokailabs.com

Key Executives

Name	Title	Year Born
Mr. Alejandro Antalich	CEO & Director	1974
Mr. Scott Edwin Ackerman	CFO, Corporate Secretary & Director	1967
Mr. Rauno Jokelainen	Operations Manager	NA
Dr. Georg Meissner	Executive Vice President of Digital Health Research & Technology	NA
Ms. Tuula Palmen	Chief Business Officer	NA
Mr. Hans J. Lauterbach	President of Europe, Asia Pacific & Middle East	NA
Mr. Alejandro Antalich	CEO & Director	1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.